Results for “ ”

Entry Author Date Location
Data in Hand, Alnylam to Seek OK for Second RNAi Drug 03/06/19 Boston
Beam Brings In $135M to Turn CRISPR Base Editing into Drugs 03/06/19 Boston
Two Years and Done: FDA Commissioner Gottlieb To Resign 03/05/19 National
Tasso Gets $6M For Device That Lets Users Self-Collect Blood Samples 03/05/19 Seattle
Angel Networks Most Active Texas Investors Since 2010, Report Says 03/05/19 Texas
Lilly to Launch “Authorized Generic” Insulin Priced at 50% Discount 03/04/19 Indiana
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy 03/04/19 Raleigh Durham
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar 03/04/19 Boston
SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future 03/01/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease 02/28/19 San Diego
7 Tips for Biotech Companies Seeking Capital in a Volatile Market 02/28/19 National
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans 02/28/19 San Francisco
With $191M Haul, Maze Therapeutics Takes Aim at Genetic Diseases 02/28/19 San Francisco
Kaleido Bio Downsizes IPO, Raises $75M for Microbiome Drug Tests 02/27/19 Boston
Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington 02/27/19 New York
Sarepta Touts More Gene Therapy Data, Snaps Up Myonexus For $165M 02/27/19 Boston
Blackstone, Novartis Start Up Anthos With $250M and a Heart Drug 02/27/19 Boston
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away 02/26/19 National
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO 02/26/19 Texas
No Details, But AstraZeneca Touts PARP Drug Win in Pancreatic Cancer 02/26/19 New York
Oyster Point Gets $93M To Clear Up Dry Eye With a Nasal Spray 02/26/19 New York
Ginkgo’s Motif Launches with $90M for Animal-Free Meat & Milk Proteins 02/26/19 Boston
Novartis to Pay $150M to Ionis, Akcea for Drug to Slow Heart Disease 02/25/19 San Diego
Bill Maris’s VC Firm Section 32 Raises $200M for Second Fund 02/25/19 San Diego
Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy 02/25/19 National
FDA Staff Hammers Karyopharm Cancer Drug on Safety, Efficacy Concerns 02/22/19 Boston
Exact Sciences Eyes Cologuard Market Expansion After “Landmark Year” 02/22/19 Wisconsin
Voyager Therapeutics, AbbVie Add Parkinson’s to Gene Therapy Pact 02/22/19 Boston
WI Watchlist: Rockwell, Wellbe, Generac, API Healthcare & More 02/22/19 Wisconsin
Page 2 of 367 « previous page · next page »